Skip to main content
Premium Trial:

Request an Annual Quote

GE Buying Thermo Fisher Businesses for $1.06B

NEW YORK (GenomeWeb News) – GE is buying Thermo Fisher Scientific's cell culture media, gene modulation, and magnetic beads business for about $1.06 billion, the companies announced today.

In aggregate the three businesses generated approximately $250 million in revenues in 2013. Thermo Fisher said it would sell the business in November in order to expedite approval by the European Commission of the company's $13.6 billion buy of Life Technologies. Isaac Ro of Goldman Sachs said at the time that the three businesses comprise less than 2 percent of Thermo Fisher's total revenues.

The Thermo Fisher-Life Tech deal is awaiting approval from the US Federal Trade Commission and is anticipated to be completed early this year.

GE said that today's deal expands its "offering of technologies for the discovery and manufacturing of new medicines, vaccines, and diagnostics in its growing Life Sciences business." Thermo Fisher's HyClone cell culture media and sera products "are highly complementary to GE Healthcare's established technologies for cell biology research and biopharmaceutical manufacturing, enabling GE to offer its customers a substantially wider range of technologies and services," they said.

Thermo Fisher's gene modulation business also complements GE's technologies for drug discovery research, while the Sera-Mag magnetic beads product line extends GE's technologies in protein analysis and medical diagnostics, they added.

The transaction is anticipated to close in the first half of the year.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.